Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 043317/0809 | |
| Pages: | 3 |
| | Recorded: | 08/17/2017 | | |
| Attorney Dkt #: | 3338.0450002/ELE/C-K/BMD |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/27/2019
|
Application #:
|
15384205
|
Filing Dt:
|
12/19/2016
|
|
Publication #:
|
|
Pub Dt:
|
06/22/2017
| | | | |
|
Title:
|
USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/02/2020
|
Application #:
|
15613192
|
Filing Dt:
|
06/03/2017
|
|
Publication #:
|
|
Pub Dt:
|
12/28/2017
| | | | |
|
Title:
|
USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT
|
|
|
Assignee
|
|
|
|
|
| 53 FRONTAGE ROAD |
| SUITE 220 |
| HAMPTON, NEW JERSEY 08827 |
|
|
Correspondence name and address
|
| |
STERNE, KESSLER, GOLDSTEIN & FOX PLLLC
|
| |
1100 NEW YORK AVENUE, NW
|
| |
WASHINGTON, DC 20005
|
Search Results as of:
05/15/2024 05:39 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
